If there’s one thing our pharmacology experts at PharmaLegacy are good at, it’s leveraging their exhaustive knowledge to facilitate the journey of your pipeline all the way to the clinical setting. Hepatic diseases and renal diseases require no introduction. Whether you are working on new liver cirrhosis treatments, or novel ways to alleviate the signs and symptoms of nephrotic syndrome, PharmaLegacy’s expert staff, who have kept more than half of the top 20 pharmaceutical companies satisfied for years in a row, is ready to advance your preclinical hepatology & nephrology studies.

Our team of experts, averaging 15 years of experience in the pharmaceutical field, armed with the most advanced hepatic & renal disease models is sure to exceed your expectations. Choose a preclinical hepatology & nephrology CRO that goes the extra mile. Work with PharmaLegacy.